266 related articles for article (PubMed ID: 15312442)
1. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
2. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
[TBL] [Abstract][Full Text] [Related]
3. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
[TBL] [Abstract][Full Text] [Related]
4. [Asymptomatic hepatitis induced by propylthiouracil].
De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
[TBL] [Abstract][Full Text] [Related]
6. Liver tests in hyperthyroidism: effect of antithyroid therapy.
Gürlek A; Cobankara V; Bayraktar M
J Clin Gastroenterol; 1997 Apr; 24(3):180-3. PubMed ID: 9179740
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests.
Aydemir S; Bayraktaroglu T; Demircan N; Sert M; Açikgoz S; Tekin IO; Ustundag Y
Int J Clin Pract; 2005 Nov; 59(11):1304-8. PubMed ID: 16236085
[TBL] [Abstract][Full Text] [Related]
8. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study.
Liaw YF; Huang MJ; Fan KD; Li KL; Wu SS; Chen TJ
Ann Intern Med; 1993 Mar; 118(6):424-8. PubMed ID: 8439116
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
[TBL] [Abstract][Full Text] [Related]
10. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
Primeggia J; Lewis JH
J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
[TBL] [Abstract][Full Text] [Related]
11. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
12. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
Gürlek A; Cobankara V; Bayraktar M
Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
[TBL] [Abstract][Full Text] [Related]
13. The propylthiouracil dilemma.
Glinoer D; Cooper DS
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil hepatitis: report of a case and extensive review of the literature.
Memi E; Karras S; Tzotzas T; Krassas GE
J Pediatr Endocrinol Metab; 2012; 25(3-4):331-43. PubMed ID: 22768665
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil-induced hepatic damage.
Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
[TBL] [Abstract][Full Text] [Related]
17. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
[TBL] [Abstract][Full Text] [Related]
19. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
20. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis induced by propylthiouracil (PTU)].
Kato H; Osajima A; Tanaka H; Serino R; Kabashima N; Tamura M; Segawa K; Anai H; Takasugi M; Nakajima Y
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):517-22. PubMed ID: 9283219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
